Medindia23h
Blujepa: First New Oral UTI Antibiotic in 30 Years
Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
Endocrinology Advisor2d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
Verywell Health on MSN2d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIs
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Pharmabiz6d
GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older
GSK plc, announced that the US FDA has approved Blujepa (gepotidacin) for the treatment of female adults (=40 kg) and paediatric patients (=12 years, =40 kg) with uncomplicated urinary tract ...
MyChesCo on MSN3d
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
New Atlas4d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Nature4d
New antibiotic for urinary tract infections nabs FDA approval
The FDA has approved GSK’s gepotidacin (Blujepa) for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older. The small-molecule drug is ...
pharmaphorum1d
GSK ends decades-long hiatus in oral antibiotics for UTIs
Gepotidacin inhibits DNA replication via two ... could claim 10 million deaths a year by 2050. "The approval of Blujepa is a crucial milestone with uUTIs among the most common infections in ...